These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25688989)

  • 21. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
    Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
    J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhodium-catalyzed ring opening of benzocyclobutenols with site-selectivity complementary to thermal ring opening.
    Ishida N; Sawano S; Masuda Y; Murakami M
    J Am Chem Soc; 2012 Oct; 134(42):17502-4. PubMed ID: 23043426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fluorous chiral dirhodium(II) complex as a recyclable asymmetric catalyst.
    Biffis A; Braga M; Cadamuro S; Tubaro C; Basato M
    Org Lett; 2005 Apr; 7(9):1841-4. PubMed ID: 15844920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silica-immobilized chiral dirhodium(II) catalyst for enantioselective carbenoid reactions.
    Chepiga KM; Feng Y; Brunelli NA; Jones CW; Davies HM
    Org Lett; 2013 Dec; 15(24):6136-9. PubMed ID: 24251986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balance between allylic C-H activation and cyclopropanation in the reactions of donor/acceptor-substituted rhodium carbenoids with trans-alkenes.
    Davies HM; Coleman MG; Ventura DL
    Org Lett; 2007 Nov; 9(24):4971-4. PubMed ID: 17956111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atomic resolution structures of the c-Src SH3 domain in complex with two high-affinity peptides from classes I and II.
    Bacarizo J; Camara-Artigas A
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):756-66. PubMed ID: 23633584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Encodable activators of SRC family kinases.
    Zellefrow CD; Griffiths JS; Saha S; Hodges AM; Goodman JL; Paulk J; Kritzer JA; Schepartz A
    J Am Chem Soc; 2006 Dec; 128(51):16506-7. PubMed ID: 17177392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The organometallic fluorine chemistry of palladium and rhodium: studies toward aromatic fluorination.
    Grushin VV
    Acc Chem Res; 2010 Jan; 43(1):160-71. PubMed ID: 19788304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regioselective synthesis of 1,2-dihydropyridines by rhodium-catalyzed hydroboration of pyridines.
    Oshima K; Ohmura T; Suginome M
    J Am Chem Soc; 2012 Feb; 134(8):3699-702. PubMed ID: 22320932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rollover cyclometalation pathway in rhodium catalysis: dramatic NHC effects in the C-H bond functionalization.
    Kwak J; Ohk Y; Jung Y; Chang S
    J Am Chem Soc; 2012 Oct; 134(42):17778-88. PubMed ID: 23013604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-selective modification of aromatic side chains with dirhodium metallopeptide catalysts.
    Popp BV; Ball ZT
    J Am Chem Soc; 2010 May; 132(19):6660-2. PubMed ID: 20420453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D2-symmetric dirhodium catalyst derived from a 1,2,2-triarylcyclopropanecarboxylate ligand: design, synthesis and application.
    Qin C; Boyarskikh V; Hansen JH; Hardcastle KI; Musaev DG; Davies HM
    J Am Chem Soc; 2011 Nov; 133(47):19198-204. PubMed ID: 22047062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-tosyloxycarbamates as a source of metal nitrenes: rhodium-catalyzed C-H insertion and aziridination reactions.
    Lebel H; Huard K; Lectard S
    J Am Chem Soc; 2005 Oct; 127(41):14198-9. PubMed ID: 16218610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence from NMR and EXAFS studies of a dynamically uniform mononuclear single-site zeolite-supported rhodium catalyst.
    Ehresmann JO; Kletnieks PW; Liang A; Bhirud VA; Bagatchenko OP; Lee EJ; Klaric M; Gates BC; Haw JF
    Angew Chem Int Ed Engl; 2006 Jan; 45(4):574-6. PubMed ID: 16380947
    [No Abstract]   [Full Text] [Related]  

  • 35. Catalytic asymmetric synthesis of pyrroloindolines via a rhodium(II)-catalyzed annulation of indoles.
    Spangler JE; Davies HM
    J Am Chem Soc; 2013 May; 135(18):6802-5. PubMed ID: 23607705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective tryptophan modification with rhodium carbenoids in aqueous solution.
    Antos JM; Francis MB
    J Am Chem Soc; 2004 Aug; 126(33):10256-7. PubMed ID: 15315433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhodium(II)-catalyzed nondirected oxidative alkenylation of arenes: arene loading at one equivalent.
    Vora HU; Silvestri AP; Engelin CJ; Yu JQ
    Angew Chem Int Ed Engl; 2014 Mar; 53(10):2683-6. PubMed ID: 24481783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.